Susquehanna Fundamental Investments, LLC Novavax Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Novavax Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 343,414 shares of NVAX stock, worth $4.57 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
343,414
Previous 313,580
9.51%
Holding current value
$4.57 Million
Previous $1.5 Billion
190.05%
% of portfolio
0.1%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$158 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$129 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$84.1 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$80.7 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $1.04B
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...